Table 3.
AMD |
Control |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Complement factor H intron | Wet | C pneu+ in wet | Dry | C pneu+ in dry | W or D unknown | C pneu+ in unknown | Total | C pneu+ in total | Total | C pneu+ |
G/G | 38 | 8 (21.0%) | 10 | 3 (30.0%) | 3 | 1 | 51 | 12 (23.5%) | 76 | 3 (4.0%) |
G/C | 32 | 4 (12.5%) | 14 | 5 (35.7%) | 7 | 0 | 53 | 9 (17.0%) | 70 | 11 (15.7%) |
C/C | 28 | 5 (17.9%) | 11 | 4 (36.4%) | 5 | 0 | 44 | 9 (20.5%) | 16 | 3 (18.8%) |
Total | 98 | 17 (17.3%) | 35 | 12 (34.2%) | 15 | 1 | 148 | 30 (20.3%) | 162 | 17 (10.5%) |
AMD, age-related macular degeneration; C pneu+, positive C pneumoniae DNA; Dry, dry AMD; Unknown, unknown AMD subtype; Wet, wet AMD.